Correspondingly, in vivo experiments again demonstrated that IPO13 promotes the progression of lung cancer by mediating RFPL3’s nuclear translocation and upregulation of hTERT expression (Fig. 6). The gene discussed is IPO13; the disease is lung carcinoma.